🇺🇸
United States · US · US:0054-0370_e1f9cc7f-de87-407e-b65b-61bc5044ce55
Lisdexamfetamine Dimesylate
In shortageOrange BookUNIISPLATC N06BA
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerHikma Pharmaceuticals USA Inc.
CountryUS (United States)
ATC codeN06BA
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc110054037025100 CAPSULE in 1 BOTTLE (0054-0370-25)
Annotations
UNII (FDA Substance ID)
SJT761GEGS
LISDEXAMFETAMINE DIMESYLATE
RxCUI 673579
Orange Book
A202827
ABABABABABABAB
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Lisdexamfetamine Dimesylate Capsule
Raw payload (JSON)
{
"unii": {
"unii": "SJT761GEGS",
"rxcui": "673579",
"inchikey": "CETWSOHVEGTIBR-FORAGAHYSA-N",
"display_name": "LISDEXAMFETAMINE DIMESYLATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"6740a621-9bec-4178-a4fc-a3fc89f34e0a": {
"match": "brand_token",
"title": "LISDEXAMFETAMINE DIMESYLATE CAPSULE [HIKMA PHARMACEUTICALS USA INC.]",
"spl_version": "7",
"published_date": "2026-05-28"
}
},
"productid": "0054-0370_e1f9cc7f-de87-407e-b65b-61bc5044ce55",
"productndc": "0054-0370",
"dosage_form": "CAPSULE",
"orange_book": {
"appl_no": "202827",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "20MG",
"product_no": "001",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "30MG",
"product_no": "002",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "40MG",
"product_no": "003",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "50MG",
"product_no": "004",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "60MG",
"product_no": "005",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "70MG",
"product_no": "006",
"approval_date": "Aug 25, 2023"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "10MG",
"product_no": "007",
"approval_date": "Jan 17, 2024"
}
],
"appl_type": "A"
},
"dea_schedule": "CII",
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "LISDEXAMFETAMINE DIMESYLATE",
"shortage_reason": "Lisdexamfetamine Dimesylate Capsule",
"shortage_status": "current",
"proprietary_name": "Lisdexamfetamine Dimesylate",
"active_ingred_unit": "mg/1",
"application_number": "ANDA202827",
"marketing_category": "ANDA",
"nonproprietary_name": "lisdexamfetamine dimesylate",
"start_marketing_date": "20230825",
"active_numerator_strength": "20"
}Related drugs
Other records sharing ATC code N06BA.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTakeda Pharmaceuticals America, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
- 🇺🇸AdderallTeva Pharmaceuticals USA, Inc.
Access this data programmatically
Query Lisdexamfetamine Dimesylate and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.